12
Views
3
CrossRef citations to date
0
Altmetric
Research Article

MEMANTINE EFFECTS ON SOMAN-INDUCED SEIZURES AND SEIZURE-RELATED BRAIN DAMAGE

Pages 227-240 | Published online: 30 Sep 2008
 

Abstract

Excitatory am ino acids have been implicated in the seizures and seizure-related brain damage (SRBD) resulting from soman intoxication. Memantine (Mem) is an open channel blocker of the glutaminergic NMDA receptor subtype reported to have anticonvulsant activity against soman. The aim of the present experiments was to evaluate the effect of Mem on electrographic seizure activity (EGSA) and SRBD produced by soman. Male rats were implanted with cortical screw electrodes for recording bipolar electrocorticogram s and allowed to recover for 5-7 days. EGSA was precipitated by injecting soman (180 mug/ kg, SC) 30 m in after HI6 (125 mg/ kg, IP) pretreatm ent. Saline, Mem (18 mg/ kg), atropine (A;10 mg/ kg), or Mem + A was adm inistered IP either 5 or 40 m in after the onset of EGSA. Saline-treated anim als displayed limbic convulsive behaviors and EGSA lasting for 4 or m ore hours. Mem or Mem + A suppressed behavioral signs of soman intoxication, but did not terminate EGSA or prevent SRBD. These results indicate that soman-induced seizures are not ameliorated by Mem or Mem + A, and that the presence or absence of som an-induced seizures cannot be verified reliably through behavioral observations alone.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.